Sana Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	73.3	71.56	50.41	28.27	21.78	4.21
Research & Development	219.84	201	306.5	257.88	119.38	9.04
Operating Expenses	293.14	272.56	356.91	286.15	141.15	13.25
Operating Income	-293.14	-272.56	-356.91	-286.15	-141.15	-13.25
Other Expense / Income	-9.89	-3.09	-0.98	-0.84	-2.83	0
Pretax Income	-283.26	-269.48	-355.93	-285.31	-138.33	-13.25
Income Tax	0	0	0	0	-7.55	0
Net Income	-283.26	-269.48	-355.93	-285.31	-130.78	-13.25
Shares Outstanding (Basic)	195	188	166	13	5	1
Shares Outstanding (Diluted)	195	188	166	13	5	1
Shares Change	3.29%	13.17%	1178.88%	165.43%	414.97%	-
EPS (Basic)	-1.46	-1.43	-2.14	-21.92	-26.68	-13.91
EPS (Diluted)	-1.46	-1.43	-2.14	-21.92	-26.68	-13.91
Free Cash Flow	-273.61	-310.93	-280.92	-161.85	-111.64	-13.96
Free Cash Flow Per Share	-1.41	-1.65	-1.69	-12.44	-22.77	-14.66
EBITDA	-245.43	-241.75	-338.01	-275.13	-134.4	-13.25
Depreciation & Amortization	37.82	27.73	17.91	10.17	3.92	0
EBIT	-283.26	-269.48	-355.93	-285.31	-138.33	-13.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).